Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	545	1,344	934	490	799	898
Market Cap Growth	-58.07%	43.98%	90.53%	-38.66%	-11.00%	108.10%
Enterprise Value	530	1,307	883	462	772	838
Last Close Price	16.80	42.15	-	-	-	-
PE Ratio	201.35	89.46	113.04	296.26	1007.78	-
PS Ratio	7.40	18.73	17.37	13.15	31.80	50.14
PB Ratio	2.88	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	4.21	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	-	379.77	3172.09	564.50	-	-
P/OCF Ratio	78.99	138.41	224.23	195.98	-	-
EV/Sales Ratio	7.08	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	41.76	135.06	515.41	387.15	-	-
EV/EBIT Ratio	84.67	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	-243.16	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.06	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.90	0.28	1.06	0.51	-	-
Debt / FCF Ratio	-	0.84	9.61	1.03	-	-
Asset Turnover	0.35	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	0.86	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.27	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.41	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	1.43%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	1.83%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	1.97%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	3.00%	4.00%	0.30%	0.30%	-1.30%	-4.10%
Earnings Yield	0.50%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	-0.40%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-1.25%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.